Professional Documents
Culture Documents
carried out to identify infrared (IR) absorption spectrum curves show that the reaction between Fe precursors
of our samples to identify the presence of iron oxide spec- and NaOH is taking place in two different stages. First
trum (Fe–O bond) with minimum residue compound in derivative of the respective titration curves indicates that
the final samples. Powder X-ray diffraction (XRD) data there are two equivalence points at which the pH
of the samples are collected on (Philips PW 1729) with changes rapidly with base titration until the end-point is
powder diffractometer with CuKα radiation sources of reached.
40 kV in the 2θ range of 20–70°. The surface morphology The occurrence of two equivalent points can be
and size of final products were characterised using the explained by the reaction of two different salts [FeSO4
scanning electron microscope (SEM) (Zeiss SUPRA and Fe(NO3)3] with different solubility at different con-
35VP). ditions ( pH value). Fe salt solution that contained diva-
The formation mechanism of Fe3O4 nanoparticle was lent (2+) and trivalent (3+) cations was initially acidic
proposed by the study of the titration curve of pH in nature. Generally, titration with 5 mL min−1 NaOH
change versus volume. The first derivative of the titration base solution triggered two important reactions. The
curve was calculated and plotted, with pH change during first reaction occurred at pH 2–4 while the second reac-
titration process. tion occurred at pH 8–9. A reddish brown precipitate
was observed during the first reaction, suggesting that
Fe may be oxidised to ferric hydroxide [Fe(OH)3] inter-
Results and discussion mediate compound.15 However, the resultant brown pre-
Solutions of Fe2+ and Fe3+ titrated with different ratio cipitation turned into black colour precipitation when
and reaction temperatures are presented in Fig. 1. pH of the solution reached the second equivalent point
Figure 1a and b shows the group of titration curves ( pH = 9), implying the formation of Fe3O4 nanoparticles
with different Fe2+/Fe3+ ratio and reaction temperatures, by co-precipitation of Fe2+ and Fe3+ ions. The reaction
while Fig. 1c shows an example of individual titration stopped at pH 12 to ensure that the precursors were
curve with calculated first derivative. Figure 1d shows fully reacted.
the respective field emission scanning electron Precipitation of divalent and trivalent Fe salts occurred
microscopy surface morphology of Fe3O4 particles syn- in alkaline medium forming black precipitate (Fe2O3
thesised with the ratio of 1:1 at 45°C. The plotted titration nanoparticle). The overall chemical reaction to synthesise
1 Titration curves of Fe2+/Fe3+ salts solution by different parameters: a temperature and b ratio. c The example of individual
titration curve with calculated first derivative and d SEM image of sample ratio of 1:1, reacted at 45°C. Both equivalent points
at different stages can be identified from the individual curve
3 Croatia, X-ray diffraction patterns of the samples synthesised with a varied temperature and b varied Fe2+/Fe3+ ratio
temperature and Fe2+/Fe3+ ratio would result in the 3. R. Hiergeist, W. Andrä, N. Buske, R. Hergt, I. Hilger, U. Richter
decrease in crystallinity of iron oxide particles. The and W. Kaiser: ‘Application of magnetite ferrofluids for hyperther-
mia’, J. Magn. Magn. Mater., 1999, 201, 420–422.
sample synthesised with a ratio of 1:1 at 45°C shows 4. H. Xu, T. Song, X. Bao and L. Hu: ‘Site-directed research of mag-
the best crystallinity among all samples. It can be con- netic nanoparticles in magnetic drug targeting’, J. Magn. Magn.
cluded that co-precipitation of magnetite iron oxide nano- Mater., 2005, 293, 514–519.
particles using ferric nitrate and ferrous sulphate should 5. S. G. Grancharov, H. Zeng, S. Sun, S. X. Wang, S. O’Brien, C. B.
Murray, J. R. Kirtley and G. A. Held: ‘Bio-functionalization of
be conducted at mild temperature with a low Fe2+/ monodisperse magnetic nanoparticles and their use as biomolecular
Fe3+ ratio in order to obtain high crystallinity labels in a magnetic tunnel junction based sensor’, J. Phys. Chem. B,
nanoparticles. 2005, 109, 13030–13035.
6. J.-K. Hsiao, M.-F. Tai, C.-Y. Yang, S.-T. Chen, J.-L. Wang,
K. Huan-Chiu and H.-M. Liu: ‘Comparison of micrometer and
nanometer sized magnetic particles for cell labeling’, IEEE Trans.
Acknowledgements Magn, 2007, 43, 2421–2423.
7. T. K. Jain, M. A. Morales, S. K. Sahoo, D. L. Leslie-Pelecky and V.
The authors would like to thank University of Malaya for Labhasetwar: ‘Iron oxide nanoparticles for sustained delivery of
funding this research work under National anticancer agents’, Mol. Pharm., 2005, 2, 194–205.
Nanotechnology Directorate (NND-53-02-03-1090), 8. S. L. McGill, C. L. Cuylear, N. L. Adolphi, M. Osinski and H. D. C.
and High Impact Research (F0032) and Smyth: ‘Magnetically responsive nanoparticles for drug delivery
applications using low magnetic field strengths’, IEEE Trans.
IPPPPostgraduates Research Grant (PG060-2013B). Nanobiosci., 2009, 8, 33–42.
9. J. Xie, S. Peng, N. Brower, N. Pourmand, S. X. Wang and S. Sun:
‘One-pot synthesis of monodisperse iron oxide nanoparticles for
potential biomedical applications’, Pure Appl. Chem., 2006, 78,
References 1003–1014.
1. Y. Shiroishi, K. Fukuda, I. Tagawa, H. Iwasaki, S. Takenoiri, H. 10. J. Park, K. An, Y. Hwang, J.-G. Park, H.-J. Noh, J.-Y. Kim, J.-H.
Tanaka, H. Mutoh and N. Yoshikawa: ‘Future options for HDD Park, N.-M. Hwang and T. Hyeon: ‘Ultra-large-scale syntheses of
storage’, IEEE Trans. Magn., 2009, 45, 3816–3822. monodisperse nanocrystals’, Nat. Mater., 2004, 3, 891–895.
2. S. Sun, C. B. Murray, D. Weller, L. Folks and A. Moser: 11. H. A. Eivari and A. Rahdar: ‘Some properties of iron oxide nano-
‘Monodisperse FePt nanoparticles and ferromagnetic FePt nano- particles synthesized in different conditions’, World Appl.
crystal superlattices’, Science, 2000, 287, 1989–1992. Program., 2013, 3, 52–55.
12. M. Mohapatra and S. Anand: ‘Synthesis and applications of nano- for simultaneous enhanced magnetic resonance imaging, fluorescence
structured iron oxides/hydroxides – a review’, Int. J. Eng. Sci. imaging, and drug delivery’, J. Am. Chem. Soc., 2009, 132, 552–557.
Technol., 2010, 2, 127–146. 15. E. G. C. Perla, A. R. G. Claudia and A. M. P. Carlos: ‘Infrared spec-
13. U. Häfeli, W. Schütt, J. Teller, M. Zborowski, eds: ‘Scientific and troscopy – materials science, engineering and technology’, in
clinical applications of magnetic carriers’, in ‘Languages of sciences’, ‘Infrared spectroscopy of functionalized magnetic nanoparticles’,
628; 1997, Germany, Springer. (ed. P. T. Theophile), 510; 2012, InTech.
14. J. E. Lee, N. Lee, H. Kim, J. Kim, S. H. Choi, J. H. Kim, T. Kim, I. C. 16. R. M. Cornell and U. Schwertmann: ‘The iron oxides: structure,
Song, S. P. Park and W. K. Moon: ‘Uniform mesoporous dye-doped properties, reactions, occurrences, and uses’, 2004, Germany,
silica nanoparticles decorated with multiple magnetite nanocrystals Wiley-VCH Verlag GmbH & Co. KGaA.